Method and apparatus for non-invasive measurement of blood analytes

• US 20060063993A1
• Filed: 09/14/2004
• Published: 03/23/2006
• Est. Priority Date: 08/09/2004
• Status: Abandoned Application

• Current Assignee: Dejin Yu, Yang Wei
• Original Assignee: Dejin Yu, Yang Wei
• Inventors: Yang, Wei, Yu, Dejin
• Application Number:
  US10/940,791
• Publication Number:
  US 20060063993A1
• Time in Patent Office: Days
• US Class Current: 600/322
• CPC Class Codes: A61B 5/0075 by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy A61B5/0071 takes precedence
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/1455 using optical sensors, e.g. spectral photometrical oximeters
• CPC Class Codes: A61B 5/6826 Finger
• CPC Class Codes: A61B 5/6834 using vacuum
• CPC Class Codes: A61B 5/702 Posture restraints
• CPC Class Codes: G01N 21/65 Raman scattering

Abstract

The present invention discloses a method and apparatus and method for achieving non-invasive measurement of analytes from human and animal blood through the skin using Raman lightwave technology. The apparatus includes a hydraulic tissue permeation unit, which controls the amount of blood in the laser tissue interaction region. Two or more spectra are obtained at different blood levels. These spectra are used to improve the measurements.

Claims

1. A non-invasive method of evaluating constituents in the blood of a patient comprising the steps of:

directing a beam of radiation to the target tissue;

measuring a first response spectrum;

modulating the target tissue to change the amount of blood in the region that is exposed to the radiation;

measuring a second response spectrum;

modulating the target tissue to change the amount of blood in the region that is exposed to the radiation;

measuring a third response spectrum;

comparing the first, second and third response spectra to identify those portions of the response most closely associated with blood in the tissue; and

predicting the constituents in the blood based on the results of the compared spectra.

2. A method as recited in claim 1, wherein the predicting step includes establishing a prediction model and validating the model based on Raman spectra associated with known levels of blood constituents.

3. A method as recited in claim 1, wherein said first, second and third response spectra are compared by performing a subtraction of magnitudes at corresponding wavelengths.

4. A method as recited in claim 1, wherein the beam of radiation is generated by a narrowband laser and the measured response spectrum corresponds to Raman Spectroscopy.

5. A method as recited in claim 1, wherein the predicting step includes comparing the results to a table of spectra associated with known levels of blood constituents.

6. A non-invasive method of evaluating constituents in the blood of a patient comprising the steps of:

applying a first negative pressure to a region of target tissue to increase the blood flow into that region;

directing optical radiation to the region;

measuring a first Raman response spectrum;

applying a second negative pressure to a region of the target tissue, said second negative pressure being different from said first negative pressure so that the blood flow in that region is changed;

measuring a second Raman response spectrum;

comparing the first and second response spectra to identify those portions of the response most closely associated with blood in the tissue; and

predicting the constituents in the blood based on the results of the compared spectra.

7. A method as recited in claim 6, wherein the predicting step includes establishing a prediction model and validating the model based on Raman spectra associated with known levels of blood constituents.

8. A method as recited in claim 6, wherein said first and second response spectra are compared by performing a subtraction of magnitudes at corresponding wavelengths.

9. A method as recited in claim 6, wherein the predicting step includes comparing the results to a table of spectra associated with known levels of blood constituents.

10. A non-invasive method of evaluating constituents in the blood of a patient comprising the steps of:

applying a first negative pressure to a region of target tissue to increase the blood flow in that region;

directing narrowband optical radiation to the region;

measuring a first Raman response spectrum;

applying a second negative pressure to the region of the target tissue, said second negative pressure being less than the first negative pressure so that blood flow in the region is reduced;

measuring a second Raman response spectrum;

subtracting the second spectrum from the first spectrum; and

predicting the constituents in the blood based on the results of the subtraction.

11. A method as recited in claim 10, wherein the predicting step includes establishing a prediction model and validating the model based on Raman spectra associated with known levels of blood constituents.

12. A method as recited in claim 10, further including the step of applying a third negative pressure to the region of the target tissue, said third negative pressure being less than the second negative pressure so that blood flow in the region is further reduced and measuring a third Raman response spectrum and wherein the third spectrum is subtracted from the second spectrum.

13. A method as recited in claim 10, wherein the predicting step includes comparing the results of the subtraction to a table of spectra associated with known levels of blood constituents

14. A non-invasive method of evaluating constituents in the blood of a patient comprising the steps of:

applying a first negative pressure to a region of target tissue to increase the blood flow in that region;

directing narrowband optical radiation to the region;

measuring a first Raman response spectrum;

applying a second negative pressure to the region of the target tissue, said second negative pressure being less than the first negative pressure so that blood flow in the region is reduced;

measuring a second Raman response spectrum;

applying a third negative pressure to the region of the target tissue, said third negative pressure being less than the second negative pressure so that blood flow in the region is reduced;

measuring a third Raman response spectrum;

subtracting the third spectrum from the first spectrum and subtracting the third spectrum from the second spectrum to obtain two difference spectra; and

evaluating the constituents in the blood based on the results of the subtractions.

15. A method as recited in claim 14, wherein the evaluating step includes comparing the results of the subtraction to a table of spectra associated with known levels of blood constituents.

16. An apparatus for non-invasively evaluating the constituents in the blood of a patient comprising:

a chamber having an opening which in use is at least partially covered by the target tissue of the patient;

a light source for directing radiation to the target tissue;

a detector for monitoring the spectral response from the target tissue and generating output signals in response thereto;

a pump for changing the pressure in the chamber in order to change the level of blood in the region of the target tissue; and

a processor for comparing the spectral responses obtained at least three different pressure levels in the chamber in order to help discriminate between the spectral response associated with the blood and the spectral response associated with the tissue, said processor further functioning to evaluate the constituents in the blood based on the results of the comparison.

17. An apparatus as recited in claim 16, wherein said chamber is filled with a fluid and said pump functions to change the amount of fluid in the chamber.

18. An apparatus for non-invasively evaluating the constituents in the blood of a patient comprising:

a chamber having an opening which in use is at least partially covered by the target tissue of the patient;

a laser light source for directing narrow band optical radiation to the target tissue;

a spectrometer detector for monitoring the Raman spectral response from the target tissue and generating output signals in response thereto;

a pump for changing the pressure in the chamber in order to change the level of blood in the region of the target tissue; and

a processor for deriving a difference spectrum by comparing the spectral responses obtained at least three different pressure levels in the chamber in order to help discriminate between the spectral response associated with the blood and the spectral response associated with the tissue, said processor further functioning to evaluate the constituents in the blood based on the results of the comparison.

19. An apparatus as recited in claim 18, wherein the spectral response of the tissue is filtered to remove wavelengths associated with the light source.

20. An apparatus as recited in claim 18, further including collection optics arranged in a confocal manner.

21. An apparatus as recited in claim 20, further including illumination optics for focusing the light onto the target tissue and additional focusing elements in the collection optics to create an image of the target tissue in a plane, and further including a confocal hole located in the image plane, said collection optics minimizing the amount of out-of-focus light reaching the detector.

22. An apparatus as recited in claim 18, wherein said chamber is filled with a fluid and said pump functions to change the amount of fluid in the chamber.

23. An apparatus for non-invasively evaluating the constituents in the blood of a patient comprising:

a laser light source for directing narrow band optical radiation to the target tissue;

a spectrometer detector for monitoring the Raman spectral response from the target tissue and generating output signals in response thereto;

means for changing the level of blood in the region of the target tissue; and

a processor for deriving a difference spectrum by comparing the spectral responses obtained at least three different levels of blood in the target tissue in order to help discriminate between the spectral response associated with the blood and the spectral response associated with the tissue, said processor further functioning to evaluate the constituents in the blood based on the results of the comparison.